论文部分内容阅读
食管静脉曲张破裂出血是门静脉高压症严重的并发症之一,首次出血死亡率高达50%～70%.内镜下硬化治疗不仅可有效控制急性出血,而且可以防止再出血,使食管静脉曲张消除,故被认为是治疗本病的主要方法.肝功能不良患者在硬化治疗过程中,注射针孔常易渗血或喷血,影响视野.严重者需再次插入三腔二囊管止血,造成内镜医师心理上的负担,影响硬化疗法的推广应用.我院于1993年4月～7月应用瑞士素高制药厂生产的立止血和5%鱼肝油酸钠在内镜下作食管静脉曲张硬化治疗,现(?)道如下.
Esophageal variceal bleeding is one of the serious complications of portal hypertension, the first bleeding mortality rate as high as 50% to 70%. Endoscopic sclerotherapy can not only effectively control acute bleeding, but also to prevent rebleeding, esophageal varices to eliminate , It is considered to be the main method of treatment of this disease.Huang dysfunction in patients with hardening of the treatment process, injection of pinhole often easy to ooze or spurt blood, affect the vision .In severe cases need to re-insert the three-chamber two capsular hemostasis, resulting in Mirror physicians psychological burden, affecting the promotion and application of sclerotherapy.Our hospital in April 1993 ~ July application of the Swiss high-tech pharmaceutical production of Liming blood and 5% sodium codlate endosurgical esophageal varices for endoscopic treatment Now (?) Road is as follows.